Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck
Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from chec...
Gespeichert in:
Veröffentlicht in: | Oral oncology 2017-04, Vol.67, p.61-69 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 69 |
---|---|
container_issue | |
container_start_page | 61 |
container_title | Oral oncology |
container_volume | 67 |
creator | Hanna, Glenn J Liu, Hongye Jones, Robert E Bacay, Alyssa F Lizotte, Patrick H Ivanova, Elena V Bittinger, Mark A Cavanaugh, Megan E Rode, Amanda J Schoenfeld, Jonathan D Chau, Nicole G Haddad, Robert I Lorch, Jochen H Wong, Kwok-Kin Uppaluri, Ravindra Hammerman, Peter S |
description | Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from checkpoint blockade. |
doi_str_mv | 10.1016/j.oraloncology.2017.02.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1882082470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1368837517300258</els_id><sourcerecordid>1882082470</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-59b4c046440c4cc084c975f9c6661b3b0e600a933a063c441bb9ae3388af71973</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxSMEoqXwFZDFiQNZxrGTOByQqpZ_UiUOwNlyJpOut4md2g7SfnscbUGIEyeP5PfezPymKF5x2HHgzdvDzgczeYd-8rfHXQW83UG1A6gfFedctV0JdSce51o0qlSirc-KZzEeICt4DU-Ls0qJXKnqvFiuabTOultmHLNunMxMA0vr7AOz87w6v-zJ-XRcKH-zQLiGQC69YTMlE5NJFlm8X83s18iQpomhCWidnw3zI0t7YnsyQ44fmCO8e148Gc0U6cXDe1H8-Pjh-9Xn8ubrpy9XlzclSlGnsu56iSAbKQElIiiJXVuPHTZNw3vRAzUAphPCQCNQSt73nSEhlDJjy7tWXBSvT7lL8PcrxaRnG7f5jKM8quZKVaAq2UKWvjtJMfgYA416CXY24ag56I24Pui_ieuNuIZKZ57Z_PKhz9pndH-svxFnwfVJQHnbn5aCjmjJIQ0200x68Pb_-rz_JwanfDg00x0dKR78GlzmqbmO2aC_bbffTs9bAVDVSvwCKyuvNw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1882082470</pqid></control><display><type>article</type><title>Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hanna, Glenn J ; Liu, Hongye ; Jones, Robert E ; Bacay, Alyssa F ; Lizotte, Patrick H ; Ivanova, Elena V ; Bittinger, Mark A ; Cavanaugh, Megan E ; Rode, Amanda J ; Schoenfeld, Jonathan D ; Chau, Nicole G ; Haddad, Robert I ; Lorch, Jochen H ; Wong, Kwok-Kin ; Uppaluri, Ravindra ; Hammerman, Peter S</creator><creatorcontrib>Hanna, Glenn J ; Liu, Hongye ; Jones, Robert E ; Bacay, Alyssa F ; Lizotte, Patrick H ; Ivanova, Elena V ; Bittinger, Mark A ; Cavanaugh, Megan E ; Rode, Amanda J ; Schoenfeld, Jonathan D ; Chau, Nicole G ; Haddad, Robert I ; Lorch, Jochen H ; Wong, Kwok-Kin ; Uppaluri, Ravindra ; Hammerman, Peter S</creatorcontrib><description>Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from checkpoint blockade.</description><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2017.02.005</identifier><identifier>PMID: 28351582</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biomarkers ; Carcinoma, Squamous Cell - immunology ; Carcinoma, Squamous Cell - pathology ; Female ; Head and neck cancer ; Head and Neck Neoplasms - immunology ; Head and Neck Neoplasms - pathology ; Hematology, Oncology and Palliative Medicine ; Humans ; Immunophenotyping ; Immunotherapy ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Otolaryngology ; PD-1 ; Squamous Cell Carcinoma of Head and Neck ; Survival</subject><ispartof>Oral oncology, 2017-04, Vol.67, p.61-69</ispartof><rights>Elsevier Ltd</rights><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-59b4c046440c4cc084c975f9c6661b3b0e600a933a063c441bb9ae3388af71973</citedby><cites>FETCH-LOGICAL-c435t-59b4c046440c4cc084c975f9c6661b3b0e600a933a063c441bb9ae3388af71973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.oraloncology.2017.02.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28351582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hanna, Glenn J</creatorcontrib><creatorcontrib>Liu, Hongye</creatorcontrib><creatorcontrib>Jones, Robert E</creatorcontrib><creatorcontrib>Bacay, Alyssa F</creatorcontrib><creatorcontrib>Lizotte, Patrick H</creatorcontrib><creatorcontrib>Ivanova, Elena V</creatorcontrib><creatorcontrib>Bittinger, Mark A</creatorcontrib><creatorcontrib>Cavanaugh, Megan E</creatorcontrib><creatorcontrib>Rode, Amanda J</creatorcontrib><creatorcontrib>Schoenfeld, Jonathan D</creatorcontrib><creatorcontrib>Chau, Nicole G</creatorcontrib><creatorcontrib>Haddad, Robert I</creatorcontrib><creatorcontrib>Lorch, Jochen H</creatorcontrib><creatorcontrib>Wong, Kwok-Kin</creatorcontrib><creatorcontrib>Uppaluri, Ravindra</creatorcontrib><creatorcontrib>Hammerman, Peter S</creatorcontrib><title>Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><description>Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from checkpoint blockade.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers</subject><subject>Carcinoma, Squamous Cell - immunology</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Female</subject><subject>Head and neck cancer</subject><subject>Head and Neck Neoplasms - immunology</subject><subject>Head and Neck Neoplasms - pathology</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Immunotherapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Recurrence, Local</subject><subject>Otolaryngology</subject><subject>PD-1</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><subject>Survival</subject><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9v1DAQxSMEoqXwFZDFiQNZxrGTOByQqpZ_UiUOwNlyJpOut4md2g7SfnscbUGIEyeP5PfezPymKF5x2HHgzdvDzgczeYd-8rfHXQW83UG1A6gfFedctV0JdSce51o0qlSirc-KZzEeICt4DU-Ls0qJXKnqvFiuabTOultmHLNunMxMA0vr7AOz87w6v-zJ-XRcKH-zQLiGQC69YTMlE5NJFlm8X83s18iQpomhCWidnw3zI0t7YnsyQ44fmCO8e148Gc0U6cXDe1H8-Pjh-9Xn8ubrpy9XlzclSlGnsu56iSAbKQElIiiJXVuPHTZNw3vRAzUAphPCQCNQSt73nSEhlDJjy7tWXBSvT7lL8PcrxaRnG7f5jKM8quZKVaAq2UKWvjtJMfgYA416CXY24ag56I24Pui_ieuNuIZKZ57Z_PKhz9pndH-svxFnwfVJQHnbn5aCjmjJIQ0200x68Pb_-rz_JwanfDg00x0dKR78GlzmqbmO2aC_bbffTs9bAVDVSvwCKyuvNw</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Hanna, Glenn J</creator><creator>Liu, Hongye</creator><creator>Jones, Robert E</creator><creator>Bacay, Alyssa F</creator><creator>Lizotte, Patrick H</creator><creator>Ivanova, Elena V</creator><creator>Bittinger, Mark A</creator><creator>Cavanaugh, Megan E</creator><creator>Rode, Amanda J</creator><creator>Schoenfeld, Jonathan D</creator><creator>Chau, Nicole G</creator><creator>Haddad, Robert I</creator><creator>Lorch, Jochen H</creator><creator>Wong, Kwok-Kin</creator><creator>Uppaluri, Ravindra</creator><creator>Hammerman, Peter S</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170401</creationdate><title>Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck</title><author>Hanna, Glenn J ; Liu, Hongye ; Jones, Robert E ; Bacay, Alyssa F ; Lizotte, Patrick H ; Ivanova, Elena V ; Bittinger, Mark A ; Cavanaugh, Megan E ; Rode, Amanda J ; Schoenfeld, Jonathan D ; Chau, Nicole G ; Haddad, Robert I ; Lorch, Jochen H ; Wong, Kwok-Kin ; Uppaluri, Ravindra ; Hammerman, Peter S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-59b4c046440c4cc084c975f9c6661b3b0e600a933a063c441bb9ae3388af71973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers</topic><topic>Carcinoma, Squamous Cell - immunology</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Female</topic><topic>Head and neck cancer</topic><topic>Head and Neck Neoplasms - immunology</topic><topic>Head and Neck Neoplasms - pathology</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Immunotherapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Recurrence, Local</topic><topic>Otolaryngology</topic><topic>PD-1</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hanna, Glenn J</creatorcontrib><creatorcontrib>Liu, Hongye</creatorcontrib><creatorcontrib>Jones, Robert E</creatorcontrib><creatorcontrib>Bacay, Alyssa F</creatorcontrib><creatorcontrib>Lizotte, Patrick H</creatorcontrib><creatorcontrib>Ivanova, Elena V</creatorcontrib><creatorcontrib>Bittinger, Mark A</creatorcontrib><creatorcontrib>Cavanaugh, Megan E</creatorcontrib><creatorcontrib>Rode, Amanda J</creatorcontrib><creatorcontrib>Schoenfeld, Jonathan D</creatorcontrib><creatorcontrib>Chau, Nicole G</creatorcontrib><creatorcontrib>Haddad, Robert I</creatorcontrib><creatorcontrib>Lorch, Jochen H</creatorcontrib><creatorcontrib>Wong, Kwok-Kin</creatorcontrib><creatorcontrib>Uppaluri, Ravindra</creatorcontrib><creatorcontrib>Hammerman, Peter S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hanna, Glenn J</au><au>Liu, Hongye</au><au>Jones, Robert E</au><au>Bacay, Alyssa F</au><au>Lizotte, Patrick H</au><au>Ivanova, Elena V</au><au>Bittinger, Mark A</au><au>Cavanaugh, Megan E</au><au>Rode, Amanda J</au><au>Schoenfeld, Jonathan D</au><au>Chau, Nicole G</au><au>Haddad, Robert I</au><au>Lorch, Jochen H</au><au>Wong, Kwok-Kin</au><au>Uppaluri, Ravindra</au><au>Hammerman, Peter S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>67</volume><spage>61</spage><epage>69</epage><pages>61-69</pages><issn>1368-8375</issn><eissn>1879-0593</eissn><abstract>Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from checkpoint blockade.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28351582</pmid><doi>10.1016/j.oraloncology.2017.02.005</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1368-8375 |
ispartof | Oral oncology, 2017-04, Vol.67, p.61-69 |
issn | 1368-8375 1879-0593 |
language | eng |
recordid | cdi_proquest_miscellaneous_1882082470 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adult Aged Aged, 80 and over Biomarkers Carcinoma, Squamous Cell - immunology Carcinoma, Squamous Cell - pathology Female Head and neck cancer Head and Neck Neoplasms - immunology Head and Neck Neoplasms - pathology Hematology, Oncology and Palliative Medicine Humans Immunophenotyping Immunotherapy Male Middle Aged Neoplasm Metastasis Neoplasm Recurrence, Local Otolaryngology PD-1 Squamous Cell Carcinoma of Head and Neck Survival |
title | Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A07%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20an%20inflamed%20tumor%20immunophenotype%20in%20recurrent,%20metastatic%20squamous%20cell%20carcinoma%20of%20the%20head%20and%20neck&rft.jtitle=Oral%20oncology&rft.au=Hanna,%20Glenn%20J&rft.date=2017-04-01&rft.volume=67&rft.spage=61&rft.epage=69&rft.pages=61-69&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2017.02.005&rft_dat=%3Cproquest_cross%3E1882082470%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1882082470&rft_id=info:pmid/28351582&rft_els_id=S1368837517300258&rfr_iscdi=true |